Affiliation:
1. Department of Bacteriology, Juntendo University, 2-1-1 Bunkyo-Ku, Tokyo, Japan 113-8421
Abstract
ABSTRACT
Six pairs of transcription profiles between glycopeptide-intermediate
S. aureus
(GISA [or vancomycin-intermediate
S. aureus
; VISA]) and glycopeptide-susceptible
S. aureus
(vancomycin-susceptible
S. aureus
[VSSA], including glycopeptide-susceptible isogenic mutants from VISA) strains were compared using a microarray. Ninety-two open reading frames which were or tended to be increased in transcription in VISA in at least five out of six array combination pairs were evaluated for their effects on glycopeptide susceptibility by introducing these genes one by one into VSSA strain N315 to construct an overexpression library. By screening the library, 17 genes including 8 novel genes were identified as associated with glycopeptide resistance since their experimental overexpression reduced vancomycin and/or teicoplanin susceptibility of N315. The raised MICs of vancomycin and teicoplanin were 1.25 to 3.0 and 1.5 to 6.0 mg/liter, respectively, as compared to 1.0 mg/liter of N315. Three of these genes, namely
graF
,
msrA2
, and
mgrA
, also raised the oxacillin MIC from 8.0 mg/liter for N315 to 64 to ∼128 mg/liter when they were overexpressed in N315. Their contribution to vancomycin and beta-lactam resistance was further supported by gene knockout and
trans
-complementation assay. By using a plasmid-based promoter-green fluorescent protein gene (
gfp
) transcriptional fusion system,
graF
promoter-activated cells were purified, and subsequent susceptibility tests and Northern blot analysis demonstrated that the cells with up-regulated activity of
graF
promoter showed reduced susceptibility to vancomycin, teicoplanin, and oxacillin. In addition, cell morphology studies showed that
graF
and
msrA2
overexpression increased cell wall thickness of N315 by factors of 23.91 and 22.27%, respectively, accompanied by glycopeptide MIC increments of 3- to 6-fold, when they were overexpressed in N315. Moreover, extended experiments and analyses indicate that many of the genes identified above are related to the cell wall biosynthetic pathway, including active nutrient transport systems. We propose that the genes which raise glycopeptide resistance in
S. aureus
function toward altering the cell wall metabolic pathway.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference56 articles.
1. Teicoplanin Stress-Selected Mutations Increasing ς
B
Activity in
Staphylococcus aureus
2. Bischoff, M., M. Roos, J. Putnik, A. Wada, P. Glanzmann, P. Giachino, P. Vaudaux, and B. Berger-Bachi. 2001. Involvement of multiple genetic loci in Staphylococcus aureus teicoplanin resistance. FEMS Microbiol. Lett.194:77-82.
3. Cloning of the Staphylococcus aureus ddh gene encoding NAD+-dependent D-lactate dehydrogenase and insertional inactivation in a glycopeptide-resistant isolate
4. A Spectrum of Changes Occurs in Peptidoglycan Composition of Glycopeptide-Intermediate Clinical
Staphylococcus aureus
Isolates
5. Cui, L., and K. Hiramatsu. 2003. Vancomycin-resistant Staphylococcus aureus, p. 187-212. In A. C. Fluit and F. J. Schmitz (ed.), MRSA: current perspectives. Caister Academic Press, Norfolk, England.
Cited by
144 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献